C9 and myeloid sarcoma: In summary, we found four different proteins (C9, CYP24A1, CP, and PLAT), with a potential role in MS susceptibility as highlighted previously from different studies, whose plasma level variability was significantly explained (≥16%) by well-established MS-risk SNPs.